Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence - Klempner, Samuel J.; Fabrizio, David; Bane, Shalmali; Reinhart, Marcia; Peoples, Tim; Ali, Siraj M.; Sokol, Ethan S.; Frampton, Garrett; Schrock, Alexa B.; Anhorn, Rachel; Reddy, Prasanth (The oncologist (Dayton, Ohio), 2020)
Keywords: Antibodies, Monoclonal - pharmacology; Antibodies, Monoclonal - therapeutic use; Antibodies/therapeutic use; Biomarkers, Tumor; DNA; DNA mutational analysis; Genes; Humans; Immunotherapy - methods; Immuno‐Oncology; Mutation; Neoplasm; Programmed cell death 1 receptor; Sequence analysis; Treatment Outcome; Tumor Burden; Neoplasm; DNA mutational analysis; DNA; Genes; Programmed cell death 1 receptor; Sequence analysis; Antibodies/therapeutic use